Literature DB >> 15236647

The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine.

J Bousquet1, C Bindslev-Jensen, G W Canonica, W Fokkens, H Kim, M Kowalski, A Magnan, J Mullol, P van Cauwenberge.   

Abstract

BACKGROUND: The definition of allergic rhinitis and the classification of its severity and treatment have advanced in recent years following the publication of the Allergic Rhinitis and its Impact of Asthma (ARIA) document. The ARIA and the European Academy of Allergology and Clinical Immunology (ARIA/EAACI) have published a set of recommendations that outline the pharmacological and clinical criteria to be met by medications commonly used in the treatment of allergic rhinitis.
METHODS: An international group of experts met to assess the profile of the antihistamine, desloratadine, under the ARIA/EAACI criteria. Data on desloratadine were collected from peer-reviewed clinical studies and review articles, which were corroborated and augmented by comprehensive public access documents from the European Medicines Evaluation Agency (EMEA). RESULTS AND
CONCLUSION: Based on this systematic review, it was concluded that the efficacy, safety and pharmacology of desloratadine broadly meet the ARIA/EAACI criteria for antihistamines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236647     DOI: 10.1111/j.1398-9995.2004.00577.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  5 in total

1.  Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.

Authors:  Deborah Layton; Lynda Wilton; Andrew Boshier; Victoria Cornelius; Scott Harris; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  [GA2LEN (Global Allergy and Asthma European Network), the perspective of the German speaking centers].

Authors:  Stefan Wöhrl; Katja Radon; Johannes Ring; Katharina Moritz; Cezmi Akdis; Peter Burney; Paul Van Cauwenberge; Jean Bousquet; Torsten Zuberbier
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 3.  Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.

Authors:  J Bousquet; A Bedbrook; W Czarlewski; G L Onorato; S Arnavielhe; D Laune; E Mathieu-Dupas; J Fonseca; E Costa; O Lourenço; M Morais-Almeida; A Todo-Bom; M Illario; E Menditto; G W Canonica; L Cecchi; R Monti; L Napoli; M T Ventura; G De Feo; W J Fokkens; N H Chavannes; S Reitsma; A A Cruz; J da Silva; F S Serpa; D Larenas-Linnemann; J M Fuentes Perez; Y R Huerta-Villalobos; D Rivero-Yeverino; E Rodriguez-Zagal; A Valiulis; R Dubakiene; R Emuzyte; V Kvedariene; I Annesi-Maesano; H Blain; P Bonniaud; I Bosse; Y Dauvilliers; P Devillier; J F Fontaine; J L Pépin; N Pham-Thi; F Portejoie; R Picard; N Roche; C Rolland; P Schmidt-Grendelmeier; P Kuna; B Samolinski; J M Anto; V Cardona; J Mullol; H Pinnock; D Ryan; A Sheikh; S Walker; S Williams; S Becker; L Klimek; O Pfaar; K C Bergmann; R Mösges; T Zuberbier; R E Roller-Wirnsberger; P V Tomazic; T Haahtela; J Salimäki; S Toppila-Salmi; E Valovirta; T Vasankari; B Gemicioğlu; A Yorgancioglu; N G Papadopoulos; E P Prokopakis; I G Tsiligianni; S Bosnic-Anticevich; R O'Hehir; J C Ivancevich; H Neffen; M E Zernotti; I Kull; E Melén; M Wickman; C Bachert; P W Hellings; G Brusselle; S Palkonen; C Bindslev-Jensen; E Eller; S Waserman; L P Boulet; J Bouchard; D K Chu; H J Schünemann; M Sova; G De Vries; M van Eerd; I Agache; I J Ansotegui; M Bewick; T Casale; M Dykewick; M Ebisawa; R Murray; R Naclerio; Y Okamoto; D V Wallace
Journal:  Clin Transl Allergy       Date:  2019-03-11       Impact factor: 5.871

4.  Review of Desloratadine Data Using the ARIA Guidelines.

Authors:  Elisa Villa; Anthi Rogkakou; Valentina Garelli; G Walter Canonica
Journal:  World Allergy Organ J       Date:  2012-01-13       Impact factor: 4.084

5.  Futura study: evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis.

Authors:  Olavo de Godoy Mion; Regis A Campos; Martti Antila; Priscila Bogar Rapoport; Nelson Rosario; João Ferreira de Mello Junior; Roberto Eustáquio Santos Guimarães; Marcos Mocellin; Giovanni Di Gesu; Dirceu Solé; Luc Wexler; João Ferreira de Mello; Fábio Morato Castro; Maria Letícia Chavarria
Journal:  Braz J Otorhinolaryngol       Date:  2009 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.